Alvarez-Rodríguez CJ, Chávez-Martín AF, García-Chávez RA, Sandoval-Zamora E, Alba-García JEG, Salcedo-Rocha AL

Language: Spanish
References: 29
Page: 247-254
PDF size: 50.85 Kb.

ABSTRACT

Objectives. To determine the life expectancy and the lost years of life in population over 40, with Diabetes mellitus (DM) and arterial Hypertension (HTA) in the state of Jalisco for 2002.
Material and Methods. Cross sectional, exploratory, and comparative study. Official data for mortality and prevalence of DM and HTA in a population of people over 40. Life expectancy was estimated by means of the of Reed Merrel method. The lost years of life were also calculated.
Results. Life expectancy in patients of the group of 40 to 45 years, with DM was 43.07 years and in patients with HTA, 45.90. Lost years of life for both gender, in Jalisco for 2002: for diabetes, 29,512, and for hypertension, 2,314.9.
Conclusions. The expectancy of life, calculated by the Reed Merrel method is useful as an indicator and as an estimate for patients over 40 years with DM and HTA. The work reflects problems related to the registration of mortality and morbidity in chronic illnesses, as well as the impact of the lost years of life due to DM and HTA.

REFERENCES

1. 1.- San Martín H. Tratado general de la salud en las sociedades humanas. Tomo III. Distrito Federal, México: La Prensa Médica Mexicana S.A. de C.V; 1992. p 523.

3. 2.- Sepulveda A J, Tapia C R, Rull J. Encuesta Nacional de Enfermedades Crónicas. Dirección General de Epidemiología. Secretaria de Salud. México; 1993.

5. 3.- Velázquez M O, Rosas P M, Lara E A, Pastelin HG, Grupo ENSA 2000, Sánchez CC, Attie F, Tapia CR. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de salud (ENSA) 2000. Arch Inst Cardiol Mex 2003; 73: 62-77.

7. 4.- Last, JM, Wallace RB. Public Health & Preventive Medicine. 13 th Edition, Norwalk.USA Appleton and Lange; 1992. p. 873 - 8.

9. 5.- García de Alba García JE, Salcedo Rocha A L. Esperanza de vida en la población usuaria del IMSS. Revista Médica del IMSS. 1998; 36:443-53.

11. 6.- García de Alba JE, Salcedo Rocha AL, Gómez Rodríguez OJ, Plascencia Campos AR. Tablas de vida para Jalisco, 1995.Cir Ciruj 1997; 65:146-50.

13. 7.- Organización Panamericana de la Salud. La salud en las América. Publicación Científica y Técnica No.587 Vol.1, Edición 2002. p8-9,296-297.

15. 8.- Lonneke V F, Di Bari M, Shorr R I, Resnick H E, Van Eijk J, et al. Type 2 diabetes in older well/functioning people who is and diagnosed? Diabetes Care 2001; 24:2065 -9.

17. 9.- American Diabetes Association: Clinical Practice Recommendations 2003. Diabetes Care 2003; 26. (Suppl 1) :s5-s20.

19. 10.- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289:2560-72.

21. 11.- Jenicek M. Epidemiología. Ediciones Científicas y Técnicas S.A. 1993. p. 307-328.

23. 12.- Tapia C.R. Encuesta Nacional de Enfermedades Crónicas en México. Higiene. 1995; 3: 174-190.

25. 13.- Arredondo A. Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries. Diabetes Care 2004; 27:104-9.

27. 14.- Secretaria de Salud. Información básica sobre recursos del sistema nacional de salud. Salud Pública Mex 2002; 45:396-407.

29. 15.- Graber JM, Corkum BE, Sonnefeld N, Kuehnerth EN. Underestimation of cardiovascular diseases mortality among Maine Americans Indians; The rol of procedural and data errors. Am J Public Health 2005; 95:827-32.